Back
Lexaria Bioscience Stock Price Chart

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
23
LEXX
Lexaria Bioscience
Last Price:
$1.03
Seasonality Move:
-11.38%
7 Day Trial
ALL ACCESS PASS
$
7

The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LEXX is experiencing slight selling pressure.
Lexaria Bioscience Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.08 | Sell |
20-day SMA: | 1.24 | Sell |
50-day SMA: | 1.4 | Sell |
200-day SMA: | 2.26 | Sell |
8-day EMA: | 1.1 | Sell |
20-day EMA: | 1.21 | Sell |
50-day EMA: | 1.38 | Sell |
200-day EMA: | 1.97 | Sell |
Lexaria Bioscience Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.11 | Sell |
Relative Strength Index (14 RSI): | 35.51 | Sell |
Chaikin Money Flow: | -7462 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.09 - 1.45) | Sell |
Bollinger Bands (100): | (1.29 - 1.99) | Sell |
Lexaria Bioscience Technical Analysis
May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Lexaria Bioscience Stock
Is Lexaria Bioscience Stock a Buy?
-
Lexaria Bioscience share price is 1.06 while LEXX 8-day simple moving average is 1.08, which is a Sell signal.
-
The stock price of LEXX is 1.06 while Lexaria Bioscience 20-day SMA is 1.24, which makes it a Sell.
-
Lexaria Bioscience 50-day simple moving average is 1.40 while LEXX share price is 1.06, making it a Sell technically.
-
LEXX stock price is 1.06 and Lexaria Bioscience 200-day simple moving average is 2.26, creating a Sell signal.
LEXX Technical Analysis vs Fundamental Analysis
Sell
23
Lexaria Bioscience (LEXX)
is a Sell
Is Lexaria Bioscience a Buy or a Sell?
-
Lexaria Bioscience stock is rated a SellThe current Lexaria Bioscience [LEXX] share price is $1.06. The Score for LEXX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
Lexaria Bioscience Stock Info
Market Cap:
20.7M
Price in USD:
1.06
Share Volume:
52.2K
Lexaria Bioscience 52-Week Range
52-Week High:
4.44
52-Week Low:
1.01
Sell
23
Lexaria Bioscience (LEXX)
is a Sell
Lexaria Bioscience Share Price Forecast
-
What is the Lexaria Bioscience stock price today?The Lexaria Bioscience stock price is 1.06 USD today.
-
Will LEXX stock go up or go down?Lexaria Bioscience> share price is forecast to RISE/FALL based on technical indicators
-
Is Lexaria Bioscience overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Lexaria Bioscience is overvalued.
Is Lexaria Bioscience Stock a Buy?
-
Lexaria Bioscience share price is 1.06 while LEXX 8-day exponential moving average is 1.10, which is a Sell signal.
-
The stock price of LEXX is 1.06 while Lexaria Bioscience 20-day EMA is 1.21, which makes it a Sell.
-
Lexaria Bioscience 50-day exponential moving average is 1.38 while LEXX share price is 1.06, making it a Sell technically.
-
LEXX stock price is 1.06 and Lexaria Bioscience 200-day simple moving average is 1.97, creating a Sell signal.
Fundamental Analysis of Lexaria Bioscience
Is Lexaria Bioscience a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Lexaria Bioscience
Should I short Lexaria Bioscience stock?
-
LEXX Moving Average Covergence Divergence (MACD) indicator is -0.11, suggesting Lexaria Bioscience is a Sell
-
Lexaria Bioscience Relative Strength Index (RSI) is 35.51, which suggest Lexaria Bioscience is oversold
-
The Bollinger Bands (25) for Lexaria Bioscience is (1.09 - 1.45), which suggest Lexaria Bioscience is a Sell
-
The Bollinger Bands (100) for Lexaria Bioscience is (1.29 - 1.99), which suggest Lexaria Bioscience is a Sell
* Lexaria Bioscience stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.